Description
A0281/6
The Idylla™ POLE-POLD1 Mutation Assay provides a rapid and reliable solution to close an important gap in oncology research by enabling molecular classification of endometrial cancer samples.
- Fully automated solution to detect 99% of the known pathogenic POLE and POLD1 mutations
- Demonstrated 98.6% accuracy with 434 endometrial cancer tissue samples
Download Leaflet: pole-pold1_ruo_-_technical_sheet_-_mar2025
Specimen requirements
-
Specimen requirements
- 1x 5 μm FFPE tissue section: 50-600 mm²
- 1x 10 μm FFPE tissue section: 25-300 mm²
- Neoplastic cells ≥10% – if less, macrodissection is required.
